Perry Johnson Laboratory Accreditation, Inc. (PJLA) now accredits Medical Marijuana Testing Laboratories. This includes a third-party assessment to ISO/IEC 17025:2017 for the relevant medical marijuana testing standard protocols to detect potency and contaminant levels in marijuana.
As many states have now legalized medical marijuana the market demand for testing laboratories will be crucial to the industry. Laboratories will need to be prepared to accommodate specific state mandates for testing protocols.
PJLA is prepared to accredit medical marijuana testing laboratories in order to accommodate regulatory and state specific requirements. We have already accredited the first medical marijuana testing laboratory in the United States.
Update: Cannabis legalization is spreading across the United States and Canada, there are many issues to take into consideration, such as federal standards for food safety in regard to cannabis products. The FDA has been able to send warning letters to food and drug manufacturers that have violated food safety procedures and controls in regard to preparation, packaging, or holding conditions of the cannabis products. However, since these products are still not legal under the federal law, regulations are not always applied. States are taking this issue into their own hands, by creating their own requirements that the cannabis industry must follow. Laboratory testing of edibles is crucial in order to preserve the health and safety of its consumers. PJLA encourages all labs to closely review their state requirements when they apply for accreditation, to ensure that they meet the needs of their customers as well as following their state’s guidelines.
Cannabis Industry Journal:
- 3 Ways to Increase Cannabis Market Accessibility via Diversity
- Financing the Cannabis Industry Part 2: A Q&A with Pelorus Equity Group Managing Partner, Travis Goad
- Ask the Experts: Ensuring the Validity of Cannabis Lab Testing
- Bad Actors in CBD: How to Distinguish Quality Products From the Rest
- Financing the Cannabis Industry Part 1: A Q&A with AFC Gamma CEO & Partner Len Tannenbaum